CT
LH icon

Clearstead Trust’s Labcorp LH Stock Holding History

Clearstead Trust’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.4K Buy
30
+8
+36% +$2.1K ﹤0.01% 661
2026
Q1 		$5.87K Buy
22
+3
+16% +$812 ﹤0.01% 721
2025
Q4 		$4.77K Sell
19
-5
-21% -$1.33K ﹤0.01% 770
2025
Q3 		$6.89K Sell
24
-8
-25% -$2.14K ﹤0.01% 683
2025
Q2 		$8.4K Buy
32
+21
+191% +$5.11K ﹤0.01% 629
2025
Q1 		$2.56K Buy
+11
New +$2.67K ﹤0.01% 732

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Clearstead Trust's LH Position: Q2 2026 in Review

Clearstead Trust increased its Labcorp (LH) stake by 36% in Q2 2026, buying an estimated $2.1K and bringing the position to 30 shares worth $8.4K. The position accounts for ﹤0.01% of the portfolio, ranked #661.

Clearstead Trust first reported a position in LH in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.4K in Q2 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Clearstead Trust held 30 shares of Labcorp worth $8.4K as of Q2 2026.
  • Clearstead Trust bought 8 Labcorp shares in Q2 2026, an estimated $2.1K.
  • Labcorp made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #661 holding.
  • Clearstead Trust first reported a position in Labcorp in Q1 2025 and has held it in 6 quarters since.
  • Clearstead Trust's Labcorp position peaked at $8.4K in Q2 2025.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.